143 related articles for article (PubMed ID: 14617797)
21. Adenovirus vector-mediated gene transfer to regional lymph nodes.
Labow D; Lee S; Ginsberg RJ; Crystal RG; Korst RJ
Hum Gene Ther; 2000 Mar; 11(5):759-69. PubMed ID: 10757355
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive of adenovirus tumor retargeting in living subjects by a soluble adenovirus receptor-epidermal growth factor (sCAR-EGF) fusion protein.
Liang Q; Dmitriev I; Kashentseva E; Curiel DT; Herschman HR
Mol Imaging Biol; 2004; 6(6):385-94. PubMed ID: 15564149
[TBL] [Abstract][Full Text] [Related]
23. Adenovirus vector covalently conjugated to polyethylene glycol with a cancer-specific promoter suppresses the tumor growth through systemic administration.
Yao X; Yoshioka Y; Morishige T; Eto Y; Narimatsu S; Mizuguchi H; Mukai Y; Okada N; Nakagawa S
Biol Pharm Bull; 2010; 33(6):1073-6. PubMed ID: 20522982
[TBL] [Abstract][Full Text] [Related]
24. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction.
Chen S; Shohet RV; Bekeredjian R; Frenkel P; Grayburn PA
J Am Coll Cardiol; 2003 Jul; 42(2):301-8. PubMed ID: 12875768
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional targeting of primary and metastatic tumor neovasculature by an adenoviral type 5 roundabout4 vector in mice.
Lu ZH; Kaliberov S; Sohn RE; Kaliberova L; Curiel DT; Arbeit JM
PLoS One; 2013; 8(12):e83933. PubMed ID: 24376772
[TBL] [Abstract][Full Text] [Related]
26. Gene therapy of a rat follicular thyroid carcinoma model with adenoviral vectors transducing murine interleukin-12.
Zhang R; DeGroot LJ
Endocrinology; 2003 Apr; 144(4):1393-8. PubMed ID: 12639922
[TBL] [Abstract][Full Text] [Related]
27. Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination.
Bramson JL; Hitt M; Gauldie J; Graham FL
Gene Ther; 1997 Oct; 4(10):1069-76. PubMed ID: 9415313
[TBL] [Abstract][Full Text] [Related]
28. Retargeting adenoviral vectors to improve gene transfer into tumors.
Hogg RT; Thorpe P; Gerard RD
Cancer Gene Ther; 2011 Apr; 18(4):275-87. PubMed ID: 21183946
[TBL] [Abstract][Full Text] [Related]
29. Adenoviral targeting of gene expression to tumors.
Hogg RT; Garcia JA; Gerard RD
Cancer Gene Ther; 2010 Jun; 17(6):375-86. PubMed ID: 20139924
[TBL] [Abstract][Full Text] [Related]
30. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
[TBL] [Abstract][Full Text] [Related]
31. Adenovirus gene transfer vectors inhibit growth of lymphatic tumor metastases independent of a therapeutic transgene.
Korst RJ; Ailawadi M; Lee JM; Lee S; Yamada R; Mahtabifard A; Crystal RG
Hum Gene Ther; 2001 Sep; 12(13):1639-49. PubMed ID: 11535167
[TBL] [Abstract][Full Text] [Related]
32. Prolonged and inducible transgene expression in the liver using gutless adenovirus: a potential therapy for liver cancer.
Wang L; Hernández-Alcoceba R; Shankar V; Zabala M; Kochanek S; Sangro B; Kramer MG; Prieto J; Qian C
Gastroenterology; 2004 Jan; 126(1):278-89. PubMed ID: 14699506
[TBL] [Abstract][Full Text] [Related]
33. Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer.
Luebke AE; Foster PK; Muller CD; Peel AL
Hum Gene Ther; 2001 May; 12(7):773-81. PubMed ID: 11339894
[TBL] [Abstract][Full Text] [Related]
34. Comparative analyses of transgene delivery and expression in tumors inoculated with a replication-conditional or -defective viral vector.
Ichikawa T; Chiocca EA
Cancer Res; 2001 Jul; 61(14):5336-9. PubMed ID: 11454670
[TBL] [Abstract][Full Text] [Related]
35. How to optimize in vivo gene transfer to cardiac myocytes: mechanical or pharmacological procedures?
Logeart D; Hatem SN; Heimburger M; Le Roux A; Michel JB; Mercadier JJ
Hum Gene Ther; 2001 Sep; 12(13):1601-10. PubMed ID: 11535164
[TBL] [Abstract][Full Text] [Related]
36. Genetic heterogeneity in response to adenovirus gene therapy.
Lefesvre P; Attema J; Lemckert A; Havenga M; van Bekkum D
BMC Mol Biol; 2003 Apr; 4():4. PubMed ID: 12697054
[TBL] [Abstract][Full Text] [Related]
37. Intratracheal injection of adenovirus containing the human MnSOD transgene protects athymic nude mice from irradiation-induced organizing alveolitis.
Epperly MW; Bray JA; Krager S; Berry LM; Gooding W; Engelhardt JF; Zwacka R; Travis EL; Greenberger JS
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):169-81. PubMed ID: 9989524
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of radiotherapy by hyperthermia-regulated gene therapy.
Lohr F; Hu K; Huang Q; Zhang L; Samulski TV; Dewhirst MW; Li CY
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1513-8. PubMed ID: 11121657
[TBL] [Abstract][Full Text] [Related]
39. Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-beta type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications.
Chung IM; Ueno H; Pak YK; Kim JW; Choi DH; Shin GJ; Yang WI; Jang Ys
Exp Mol Med; 2002 Sep; 34(4):299-307. PubMed ID: 12515396
[TBL] [Abstract][Full Text] [Related]
40. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
